Board and Officer Appointments and Company Address Change

Invex Therapeutics Limited (Invex, ASX:IXC, or the Company) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Director Appointments The Company is ple